治疗充血性心力衰竭药物进展
被引量：2
Advances in the Treatment of Congestive Heart Failure
摘要
心力衰竭 (心衰 )是一种慢性、致命性疾病 ,已成为引起死亡的一个很大病因 ,治疗费用非常高。目前用于治疗心衰的药物大多数是从其它的心血管疾病治疗药中发现的 ,仅有少数药物是专门设计用于心衰治疗。
出处
《药物流行病学杂志》
CAS
2003年第4期194-197,共4页
Chinese Journal of Pharmacoepidemiology
参考文献19
-
1Rich M W. Management of chronic heart failure. Drugs of Today, 1999,35(1) : 171-179.
-
2Wong PC, William AP, Andrew TC, et al. Nonpeptide angiotensin Ⅱ receptor antagonists. Scip World Pharmaceutical News, 1997,22: 2216.
-
3Robl JA, Sun CQ, Stevenson J, et al. Dual metalloprotase inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase. J Med Chem, 1997,40(11):1570-1577.
-
4Graul A, Leeson P, Castaner J, et al. Omapatrilat. Drugs of the Future, 1999,24(2) : 269-277.
-
5Robl JA, Sulsky R, Sieber E, et al. Vasopeptidase inhibitors: incorporation of ceminal and spirocyclic substituted azepinones in mercaptoacyl dipeptides. J Med Chem, 1999,42(2) :305-311.
-
6Yoshikawa T, Port JD, Asano K,et al. Carvedilol in heart failure, J Eur heart, 1996,17(suppl) :B2-B16.
-
7Bristow MR, Carvedilol in patients with heart failure. Am J Cardiol, 1997,80(11A) :L26-L40.
-
8Billman GE,Castillo LC,Hensley J,et al.Current drug treat with β-blockers. Circulation. 1997,96(6) : 1914-1922.
-
9Feuserstein GZ,Bril A,Ruffolo RR Jr.The next generation in heart failure therapy. Am J Cardiol, 1997, 80(11A):L41-L45.
-
10Krum H. β-Blockers in heart failure. Drugs, 1999, 58(2) :203-210.
同被引文献9
-
1Ferrari R, Ceconi C, Curello S, et al. Left ventricular dysfunctionduo to the new ischemic outcomes:stunning and hibernation. J Cardiovasc pharmacol,1996,28(Suppl):S18-16.
-
2Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure:randomised trial:the Losartan Heart Failure Survival Study ELITE Ⅱ. Lancet, 2000;255:1582-1587.
-
3Di Lenarda A, Sabbadini G, Salvatore L, et al. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dyfunction despite chronic metoprolol. J Am Coll Cardiol,1999,33;1926-34.
-
4GrasD, MaboP, YangT, et al. Multisite pacing as a sup-plemental treatment of congestive heart failure:prelimi-nary results of the Medtronic Insync Study. PACE, 1998,21:2249-2255.
-
5RobertV,SilvestreJS,CharlemafneD,et al.Biological determin antsofaldosterone-induced cardiacfibrosisinrats.Hypertension,1995,26 (6Pt1):971.
-
6Bertram P,Faiez Z,Willem J,et al.Theeffectofspironolactoneon morbidity and mortality in patients with severe heart failure.N Engl J Med,1999,9(2):709.
-
7华伟,王方正,张澍,张奎俊,牛国栋,陈新.三腔双心室起搏治疗20例充血性心力衰竭患者的近期临床效果[J].中华心律失常学杂志,2001,5(1):38-40. 被引量：5
-
8伍旭升,张祖茂,金松元,张高峰.米力农治疗充血性心力衰竭的临床研究[J].中国临床药学杂志,2001,10(3):146-148. 被引量：8
-
9李勇,范维琥.心力衰竭药物治疗的临床新进展[J].世界临床药物,2003,24(1):8-15. 被引量：12
引证文献2
-
1凌锋,沈法荣,黄抒伟,俞蔚,陈建明,王志军,陈旭娇.慢性充血性心力衰竭综合治疗的临床观察[J].心脑血管病防治,2005,5(2):25-27. 被引量：2
-
2方伟.盐酸咪哒普利和螺内酯治疗慢性充血性心力衰竭61例[J].陕西医学杂志,2007,36(4):499-500.
-
1易寄东,田英.实验性呼吸窘迫综合征大鼠肺组织中糖皮质激素受体与肾上腺...[J].中华结核和呼吸杂志,1993,16(1):15-17. 被引量：3
-
2油酸型肺损伤大鼠肺组织β和α1受体的变化及山莨菪碱对...[J].中华结核和呼吸杂志,1993,16(1):11-12. 被引量：4
-
3张德省.缬沙坦治疗慢性心力衰竭38例临床效果分析[J].中国医药指南,2013,11(13):87-88. 被引量：1
-
4Studer JA,戴富林.α-肾上腺素能阻滞剂在老年病人中的使用进展(Ⅰ)[J].国外医学（老年医学分册）,1993,14(6):267-270.
-
5Khor.,AF,胡大一.高血压的α—阻断剂治疗[J].美国医学会杂志（中文版）,1992,11(3):138-143.
-
6穆传深,邵传章.耐甲氧西林金黄色葡萄球菌耐药机制及治疗药物进展[J].药物分析杂志,1995,15(A01):572-575.
-
7黄欣.治疗肥胖的药物进展[J].山东医药工业,1999,18(2):19-20.
-
8王春阁,张弋.治疗肝移植术后乙肝复发的药物进展[J].中国临床药理学与治疗学,2002,7(3):283-285. 被引量：5
-
9陈亮,杨华章.糖尿病口服药物进展及其临床应用[J].辽宁实用糖尿病杂志,2002,10(2):54-56. 被引量：17
-
10曲静伟.抗充血性心力衰竭药物进展[J].现代实用医学,2002,14(1):38-40.
